• Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub
  •  0 items - £0.00
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • My account
  •  0 items - £0.00

Action Duchenne

Header Right

  • Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub

News

You are here: Home / News

Newly diagnosed family online event

23 September 2022 by Lynnette

Building your foundation of Duchenne knowledge Online via ZoomSaturday 22nd October 202214:00 - 17:00 GMTAll welcome More information An …

Newly diagnosed family online eventRead More

Conference agenda

20 September 2022 by Lynnette

Join us for two days in November as we explore the latest research, treatments and updates. Watch presentations, Q&A sessions and join discussions …

Conference agendaRead More

Edgewise announces FDA authorisation for Phase 2 clinical trial

8 September 2022 by Lynnette

Edgewise has announced the FDA has authorized Phase 2 clinical trial for the treatment of Duchenne. The Lynx trial is a placebo-controlled trial to …

Edgewise announces FDA authorisation for Phase 2 clinical trialRead More

Sarepta Therapeutics announces scholarship program

8 September 2022 by Lynnette

Twenty exceptional individuals living with Duchenne muscular dystrophy will receive a scholarship of up to $5,000 as they pursue their post-secondary …

Sarepta Therapeutics announces scholarship programRead More

PTC reveals winners of STRIVE awards on World Duchenne Awareness Day

7 September 2022 by Lynnette

Over the past few months, we are proud to have shared photos, updates and stories from our ‘Yes I can’ project. You’ll have seen the looks of …

PTC reveals winners of STRIVE awards on World Duchenne Awareness DayRead More

Sarepta updates on MOMENTUM clinical trial

6 September 2022 by Lynnette

Sarepta Therapeutics has announced that the FDA has lifted its clinical hold on SRP-5051 (vesleteplirsen). Designed to skip exon 51 of the …

Sarepta updates on MOMENTUM clinical trialRead More

Pfizer shares update on Phase 2 DAYLIGHT clinical trial

6 September 2022 by Lynnette

We are pleased to share an update with you from US based pharmaceutical and biotechnology corporation, Pfizer about their clinical …

Pfizer shares update on Phase 2 DAYLIGHT clinical trialRead More

Action Duchenne International Conference

17 August 2022 by Lynnette

‘Educating, enabling and including’ is the theme of the unmissable 20th Action Duchenne International Conference, which launches this week. Bringing …

Action Duchenne International ConferenceRead More

PTC transition survey

16 August 2022 by Lynnette

We are working with PTC Therapeutics to get answers to important questions about transition from paediatric to adult care.  PTC would like to …

PTC transition surveyRead More

Sarepta recruiting for MIS51ON exon skipping study

15 August 2022 by Lynnette

Sarepta has announced they are recruiting for their MIS51ON clinical research study in the UK. A randomized, double-blind, dose finding and …

Sarepta recruiting for MIS51ON exon skipping studyRead More

Translarna update

21 July 2022 by Lynnette

The treatment ataluren (Translarna) for Duchenne muscular dystrophy has now exited managed access and entered the NICE re-evaluation process. In order …

Translarna updateRead More

Step by step guide to the EHCP process

11 July 2022 by Samantha

In this session Clair Warner, SEATTS PD Team Manager, shares her decades of specialist knowledge and experience to help our families navigate the …

Step by step guide to the EHCP processRead More

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Interim pages omitted …
  • Page 49
  • Go to Next Page »

Footer

Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA

0300 102 1762
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

Site Footer

Fundraising Regulator badge with validation link

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852